ArticleJournal of managed care & specialty pharmacy2021
Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics.
Dominic Pilon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.